In Vivo Laser-Mediated Retinal Ganglion Cell Optoporation Using KV1.1 Conjugated Gold Nanoparticles
Source abstract
Abstract
Vision loss caused by retinal diseases affects hundreds of millions of individuals worldwide. The retina is a delicate central nervous system tissue stratified into layers of cells with distinct roles. Currently, there is a void in treatments that selectively target diseased retinal cells, and current therapeutic paradigms present complications associated with off-target effects. Herein, as a proof of concept, we introduce an in vivo method using a femtosecond laser to locally optoporate retinal ganglion cells (RGCs) targeted with functionalized gold nanoparticles (AuNPs). We provide evidence that AuNPs functionalized with an antibody toward the cell-surface voltage-gated K+ channel subunit KV1.1 can selectively deliver fluorescently tagged siRNAs or fluorescein isothiocyanate-dextran dye into retinal cells when irradiated with an 800 nm 100 fs laser. Importantly, neither AuNP administration nor irradiation resulted in RGC death. This system provides a novel, non-viral-based approach that has the potential to selectively target retinal cells in diseased regions while sparing healthy areas and may be harnessed in future cell-specific therapies for retinal degenerative diseases.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Retinal Development and Disorders · Photoreceptor and optogenetics research · Neuroscience and Neural Engineering
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Engineering Physics, Polytechnique Montréal, Montreal, Quebec, Canada, H3C 3A7
Funding
Government of Canada · Foundation Fighting Blindness · Canada Research Chairs · Canadian Diabetes Association · Heart and Stroke Foundation of Canada · Consortium Quebecois sur la Decouverte du Medicament
References (61)
Show source-provided references
1. 10.1001/jamaophthalmol.2016.262710.1001/jamaophthalmol.2016.2627 ↗
2. 10.1016/j.ophtha.2014.05.01310.1016/j.ophtha.2014.05.013 ↗
3. Medical Letter on Drugs & Therapeutics · 2018 · 60 · 53
4. 10.1016/j.exer.2011.07.00110.1016/j.exer.2011.07.001 ↗
5. 10.1038/mt.2012.28010.1038/mt.2012.280 ↗
6. 10.3129/i07-04910.3129/i07-049 ↗
7. 10.1167/iovs.16-2078610.1167/iovs.16-20786 ↗
8. 10.1136/bjophthalmol-2013-30388510.1136/bjophthalmol-2013-303885 ↗
9. 10.1016/j.biomaterials.2011.11.06210.1016/j.biomaterials.2011.11.062 ↗
10. 10.1039/C5NR05650K10.1039/C5NR05650K ↗
11. Ding W. · 2015 · 33110.1533/9781908818782.331 ↗
12. 10.1016/j.jphotochemrev.2013.06.00110.1016/j.jphotochemrev.2013.06.001 ↗
13. 10.1186/s12951-014-0057-110.1186/s12951-014-0057-1 ↗
14. 10.1021/nl302200w10.1021/nl302200w ↗
15. 10.1039/C6NR08773F10.1039/C6NR08773F ↗
16. 10.1002/jbio.20150013510.1002/jbio.201500135 ↗
17. 10.1039/C5NR02721G10.1039/C5NR02721G ↗
18. 10.1038/8668410.1038/86684 ↗
19. 10.1039/C6NR01257D10.1039/C6NR01257D ↗
20. 10.1021/acsphotonics.6b0065210.1021/acsphotonics.6b00652 ↗
21. 10.1021/acs.nanolett.6b0056210.1021/acs.nanolett.6b00562 ↗
22. 10.1016/j.preteyeres.2013.04.00110.1016/j.preteyeres.2013.04.001 ↗
23. 10.1371/journal.pone.004983010.1371/journal.pone.0049830 ↗
24. 10.1167/iovs.08-326710.1167/iovs.08-3267 ↗
25. 10.1002/cne.2352110.1002/cne.23521 ↗
26. 10.1016/0306-4522(84)90195-710.1016/0306-4522(84)90195-7 ↗
27. 10.1167/iovs.09-409810.1167/iovs.09-4098 ↗
28. 10.1016/j.brainres.2007.07.09010.1016/j.brainres.2007.07.090 ↗
29. 10.1038/340035a010.1038/340035a0 ↗
30. 10.1073/pnas.83.12.432710.1073/pnas.83.12.4327 ↗
31. 10.1002/(SICI)1096-9861(20000529)421:2<215::AID-CNE7>3.0.CO;2-U10.1002/(SICI)1096-9861(20000529)421:2<215::AID-CNE7>3.0.CO;2-U ↗
32. 10.1002/jnr.2110510.1002/jnr.21105 ↗
33. 10.1039/C6NR01257D10.1039/C6NR01257D ↗
34. 10.1016/j.biomaterials.2013.04.03510.1016/j.biomaterials.2013.04.035 ↗
35. 10.1007/s11095-008-9745-610.1007/s11095-008-9745-6 ↗
36. 10.1016/j.biomaterials.2012.01.03010.1016/j.biomaterials.2012.01.030 ↗
37. 10.1002/jbio.20140002510.1002/jbio.201400025 ↗
38. 10.2174/187436410100401005210.2174/1874364101004010052 ↗
39. 10.1111/j.1476-5381.1984.tb10760.x10.1111/j.1476-5381.1984.tb10760.x ↗
40. 10.1016/0014-4835(86)90026-610.1016/0014-4835(86)90026-6 ↗
41. 10.1073/pnas.090927610710.1073/pnas.0909276107 ↗
42. 10.1523/JNEUROSCI.2635-12.201310.1523/JNEUROSCI.2635-12.2013 ↗
43. 10.1089/neu.1999.16.15310.1089/neu.1999.16.153 ↗
44. 10.1167/iovs.10-673810.1167/iovs.10-6738 ↗
45. 10.1172/jci.insight.12155510.1172/jci.insight.121555 ↗
46. 10.1364/BOE.7.00514810.1364/BOE.7.005148 ↗
47. 10.1073/pnas.141016211110.1073/pnas.1410162111 ↗
48. 10.1038/3588810.1038/35888 ↗
49. 10.1096/fj.00-0598fje10.1096/fj.00-0598fje ↗
50. 10.1371/journal.pone.000355410.1371/journal.pone.0003554 ↗
51. 10.1001/archopht.1995.0110012006801210.1001/archopht.1995.01100120068012 ↗
52. Hirsch L. R. · 2005 · 303 · 10110.1385/1-59259-901-X:101 ↗
53. 10.1002/jbio.20130016510.1002/jbio.201300165 ↗
54. 10.1002/jbio.20140002510.1002/jbio.201400025 ↗
55. 10.1021/la301390u10.1021/la301390u ↗
56. 10.1038/protex.2011.21510.1038/protex.2011.215 ↗
57. 10.1167/iovs.10-687310.1167/iovs.10-6873 ↗
58. 10.1172/JCI3381310.1172/JCI33813 ↗
59. 10.1172/JCI3169210.1172/JCI31692 ↗
60. Pang J.-J. · Molecular vision · 2005 · 11 · 152
61. 10.1002/jnr.2080310.1002/jnr.20803 ↗